+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Spinal Fusion Devices Market Size, Share & Industry Trends Analysis Report By Surgery, By Type, By End User (Hospitals, Specialty Clinics, and Others), By Regional Outlook and Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 199 Pages
  • April 2022
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5600814
The Global Spinal Fusion Devices Market size is expected to reach $9.7 billion by 2028, rising at a market growth of 4.6% CAGR during the forecast period.

Spinal instrumentation also called spinal implants, devices, or hardware involves the implantation of titanium, stainless steel, titanium-alloy, or non-metallic items into the spine by surgical procedures. Spinal instrumentation is a long-term remedy for spinal instability. Medical implants come in a variety of forms, styles, and sizes, all of which are designed to treat spinal diseases in people of all age groups. Spinal fusion devices are used to treat spondylolisthesis and degenerative disc disease, as well as other spinal abnormalities. The rise in the elderly population along with the rise in the prevalence of spinal disorders is driving the Market 's growth. Furthermore, the Market is expected to rise as the number of indications for spinal fusion surgery grows. For example, spinal fusion was once reserved for spinal tuberculosis & scoliosis, but it is now used to treat 14 other disorders.

In men & women over the age of 50, spine problems like spinal stenosis are the most common condition. The elderly, especially those with comorbidities and/or reduced immunity, are at a higher risk of spinal abnormalities. With the emergence of new-age spine fusion and gadgets, spine-level therapy choices are always increasing. In addition, the usage of these implants and devices is one of the most successful and well-recommended treatments for spine misalignments and degenerative alterations. The trend toward less invasive spine operations, the rise in the prevalence of spinal illnesses, and innovations in spine surgery are all major factors driving the growth of the spinal fusion devices Market.

Surgeons are choosing MIS over open surgery for a variety of reasons, including less pain, a shorter recovery time, and less tissue damage. Minimally invasive procedures are being used to treat a wide spectrum of bone problems. In the United States, around 400,000 spinal fusion procedures are performed each year, making it one of the most prevalent and well-established treatment choices for spine trauma, degenerative conditions, and structural anomalies.



COVID-19 Impact Analysis

COVID-19 has spread all over the world. In addition, because of a rise in the number of coronavirus patients, governments all over the world have implemented several regulations and lockdowns, resulting in the closure of manufacturing & production operations of companies in the spinal fusion devices industry. Moreover, as surgeons and Practitioners focus on treating corona patients, hospitals have announced reductions, postponement, or cancellations of elective procedures, including many orthopaedic and spine cases. This break in the flow of business operations and other relevant activities has a direct impact on the Market. As a result, the above-mentioned factors are estimated to restrain the growth of the spinal fusion devices Market.

Market driving Factors:


The Development of Robotic Spine Fusion Surgery

Surgical robots are increasingly being used in the spine treatment industry, with several hospitals now giving robotic surgery for the treatment of numerous spinal injuries and disorders. Many companies are focusing on developing surgical robots that may be utilized in conjunction with their implants & navigation aids in spinal fusion surgery. This has majorly increased the number of strategic partnerships as well as new product launches, all of which are estimated to propel the Market forward. Medtronic announced the launch of Mazor X Stealth Edition, a robotic system for spine surgery, in January 2019. The technology may be combined with the company's navigation, spine implants, and 3D imaging capabilities to provide healthcare providers with a complete solution.

Rising number of novel innovations across the spinal fusion Market

The Market for spinal arthrodesis devices is fiercely competitive, with major competitors launching new and sophisticated products regularly to sustain their position in the Market. Moreover, minimally invasive operations are gaining adoption around the world, prompting manufacturers to introduce devices designed specifically for minimally invasive spinal fusion surgery. Alphatec Spine, for instance, announced the commercial introduction of Invictus, a spine fixation platform created for open, minimally invasive, or hybrid surgical procedures, in July 2019. The increasing number of advancements and innovations in the spinal fusion devices is expected to significantly boost demand for these devices.

Market ing Restraining Factor:


Risk of Spinal discomfort & longer healing time due to bone grafting

A fusion entails substantial bone grafting, which might result in increased back discomfort and an increased healing time. Throughout a fusion, the lateral facet joints & transverse processes, which are parts of pine that are placed on the sides of each vertebra, are usually exposed. More muscle dissection is required as a result. Bone grafts or bone substitutes are also used in the spine to aid in the gradual fusion of the bones, although this might cause inflammation, which can add to additional scarring, or arachnoiditis, and pain.



Surgery Outlook

Based on Surgery, the Market is segmented into Minimally Invasive Spine Surgery and Open Spine Surgery. The Open Spine surgery garnered substantial revenue share in spinal fusion devices Market in 2021. The growing desire for open spine procedures among medical professionals, the increasing incidence of spinal abnormalities, and technological breakthroughs in spinal fusion surgery all contribute to growth of this segment. Tele audiology can be a useful approach for persons who are experiencing hearing loss during this period to get the care that eliminates or limits conventional face-to-face engagement.

Type Outlook

Based on Type, the Market is segmented into Thoracolumbar Devices, Cervical Fixation Devices, and Interbody Fusion Devices. The Cervical Fixation devices segment procured a significant revenue share in the spinal fusion devices Market in 2021 because of rapid adoption of spine navigation software and attractive health insurance coverage. Cervical plates help fusion by keeping the construct stable. The novel cervical interbody device is comprised of titanium alloy and is cylindrical. The device collects bone material needed for fusion as it is inserted between two vertebrae.

End User Outlook

Based on End User, the Market is segmented into Hospitals, Specialty Clinics, and Others. The Hospitals segment acquired the highest revenue share in spinal fusion devices Market in 2021. Because of the increasing adoption of advanced spine surgery products along with the progressive growth in the number of robotic spine surgeries, in addition hospitals are witnessing significant cost savings from spinal fusion procedures, which is expected to boost the Market even further.

Regional Outlook

Based on Regions, the Market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America acquired the highest revenue share of the spinal fusion Market in 2021. The regional Market is likely to be fueled by a significant increase in the number of spinal fusion procedures performed in ambulatory surgical centers and outpatient settings, as well as the rapid use of spine navigation tools and surgical robots. Significant number of adults in the United States experienced chronic pain in 2016, with few among them experiencing high-impact chronic pain. During the projection period, this is likely to boost demand for spine fusion implants in the United States.

The Market research report covers the analysis of key stake holders of the Market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., Johnson & Johnson, Stryker Corporation, B. Braun Melsungen AG, Medtronic PLC, Alphatec Holdings Inc., Globus Medical, Inc., NuVasive, Inc., Orthofix Medical, Inc., and Exactech, Inc.

Recent Strategies Deployed in Spinal Fusion Devices Market

  • Feb-2022: Orthofix Medical introduced Opus BA for commercial use in the Market. It is a synthetic bioactive bone graft solution for cervical & lumbar spine fusion procedures. It can be used to fill voids in the bone or skeletal system's gap that is not inherent to the balance of bony structure. In addition, Opus BA mimics a scaffold permitting bone growth over the surface that is reabsorbed & substituted with natural bone during the healing process.
  • Jan-2022: Exactech signed an agreement to acquire JointMedica, a U.K based orthopedic device designer & manufacturer. This collaboration aimed to give the coming generation of hip resurfacing to the global Market with JointMedica, the Polymotion hip implant.
  • Sep-2021: Alphatec Holdings introduced the InVictus OsseoScrew Expandable Spinal Fixation System. This system is created to be a substitute for the traditional use of cemented fenestrated screws for patients with compromised bone. The system is made with an intention to again store spinal column integrity, even in the absence of fusion, in patients with advanced-stage tumors involving the lumbar & thoracic spine in whom life expectancy is of not sufficient duration to allow achievement of fusion.
  • Apr-2021: Globus Medical released the new product CREO ONE, the first robotic screw in the Market created for spine surgery with ExcelsiusGPS. This new release is expected to improve the company's groundbreaking modular pedicle screw platform by making simple pedicle preparation while maintaining the precision of navigation & raising pullout strength by 86% in comparison with conventional pedicle screws tapped to size.
  • Feb-2021: NuVasive completed the acquisition of Simplify Medical, a private company & developer of Simplify Cervical Artificial Disc (Simplify Disc) for cervical total disc replacement (cTDR). This acquisition aimed to distinguish NuVasive's cervical portfolio and sums up the most clinically effective cTDR technology in the Market.
  • Nov-2020: Medtronic took over Medicrea, a french artificial intelligence company. Under this acquisition, Medicrea's technology is expected to be combined into the Spine of Medtronic division. This acquisition aimed to offer an integrated solution comprising artificial intelligence-driven personalized spinal implants, surgical planning, and robotic-assisted surgical delivery, which is expected to give them control of these smart technologies straight into the hands of clinicians to make patient care more personalized & tailored.
  • Sep-2019: DePuy Synthes, a Johnson & Johnson Medical Devices Companies introduced CONDUIT Interbody Platform with EIT Cellular Titanium Technology, which is expected to widen its offering to treat degenerative spine disease. This innovative portfolio comprises 3D printed titanium interbody, which is expected to carry out spinal fusion surgery to imitate natural bone & help facilitate spinal fusion.
  • Aug-2019: NuVasive unveiled Modulus TLIF-A for commercial use. It is a porous titanium spine implant engineered for the transforaminal lumbar interbody fusion (TLIF) procedure. This offering completes the Company's Advanced Materials Science (AMS) portfolio for all major posterior interbody fusion techniques used in TLIF, the most usually performed procedure in the spine industry. The availability of Modulus TLIF-A furthermore extends NuVasive's technology contribution to the spinal deformity Market given its differentiated ability to deliver anterior column support, raise segmental maximize the capability to restore sagittal alignment & lordosis.
  • Jul-2019: Alphatec Holdings unveiled IdentiTi Large Window Porus Titanium Interbody Implant System for commercial use. This system is for anterior lumbar interbody fusion (ALIF) procedures, which is manufactured using a subtractive process that generates more predictable performance.
  • Sep-2018: Johnsons & Johnsons, a subsidiary of Johnsons & Johnsons Medical Devices signed an agreement to acquire Emerging Implant Technologies GmbH (EIT), a privately-held manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery, located in Wurmlingen, Germany. This acquisition aimed to permit DePuy Synthes, to improve its comprehensive interbody implant portfolio that comprises expandable interbody devices, titanium integrated PEEK technology & 3D-printed cellular titanium, for both open spinal surgery & minimally invasive.

Scope of the Study


Market Segments Covered in the Report:


By Surgery
  • Minimally Invasive Spine Surgery
  • Open Spine Surgery
By Type
  • Thoracolumbar Devices
  • Cervical Fixation Devices
  • Interbody Fusion Devices
By End User
  • Hospitals
  • Specialty Clinics
  • Others

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players


List of Companies Profiled in the Report:

  • Zimmer Biomet Holdings, Inc.
  • Johnson & Johnson
  • Stryker Corporation
  • B. Braun Melsungen AG
  • Medtronic PLC
  • Alphatec Holdings Inc.
  • Globus Medical, Inc.
  • NuVasive, Inc.
  • Orthofix Medical, Inc.
  • Exactech, Inc.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Spinal Fusion Devices Market, by Surgery
1.4.2 Global Spinal Fusion Devices Market, by Type
1.4.3 Global Spinal Fusion Devices Market, by End User
1.4.4 Global Spinal Fusion Devices Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Spinal Fusion Devices Market
Chapter 4. Global Spinal Fusion Devices Market by Surgery
4.1 Global Minimally Invasive Spine Surgery Market by Region
4.2 Global Open Spine Surgery Market by Region
Chapter 5. Global Spinal Fusion Devices Market by Type
5.1 Global Thoracolumbar Devices Market by Region
5.2 Global Cervical Fixation Devices Market by Region
5.3 Global Interbody Fusion Devices Market by Region
Chapter 6. Global Spinal Fusion Devices Market by End User
6.1 Global Hospitals Market by Region
6.2 Global Specialty Clinics Market by Region
6.3 Global Others Market by Region
Chapter 7. Global Spinal Fusion Devices Market by Region
7.1 North America Spinal Fusion Devices Market
7.1.1 North America Spinal Fusion Devices Market by Surgery
7.1.1.1 North America Minimally Invasive Spine Surgery Market by Country
7.1.1.2 North America Open Spine Surgery Market by Country
7.1.2 North America Spinal Fusion Devices Market by Type
7.1.2.1 North America Thoracolumbar Devices Market by Country
7.1.2.2 North America Cervical Fixation Devices Market by Country
7.1.2.3 North America Interbody Fusion Devices Market by Country
7.1.3 North America Spinal Fusion Devices Market by End User
7.1.3.1 North America Hospitals Market by Country
7.1.3.2 North America Specialty Clinics Market by Country
7.1.3.3 North America Others Market by Country
7.1.4 North America Spinal Fusion Devices Market by Country
7.1.4.1 US Spinal Fusion Devices Market
7.1.4.1.1 US Spinal Fusion Devices Market by Surgery
7.1.4.1.2 US Spinal Fusion Devices Market by Type
7.1.4.1.3 US Spinal Fusion Devices Market by End User
7.1.4.2 Canada Spinal Fusion Devices Market
7.1.4.2.1 Canada Spinal Fusion Devices Market by Surgery
7.1.4.2.2 Canada Spinal Fusion Devices Market by Type
7.1.4.2.3 Canada Spinal Fusion Devices Market by End User
7.1.4.3 Mexico Spinal Fusion Devices Market
7.1.4.3.1 Mexico Spinal Fusion Devices Market by Surgery
7.1.4.3.2 Mexico Spinal Fusion Devices Market by Type
7.1.4.3.3 Mexico Spinal Fusion Devices Market by End User
7.1.4.4 Rest of North America Spinal Fusion Devices Market
7.1.4.4.1 Rest of North America Spinal Fusion Devices Market by Surgery
7.1.4.4.2 Rest of North America Spinal Fusion Devices Market by Type
7.1.4.4.3 Rest of North America Spinal Fusion Devices Market by End User
7.2 Europe Spinal Fusion Devices Market
7.2.1 Europe Spinal Fusion Devices Market by Surgery
7.2.1.1 Europe Minimally Invasive Spine Surgery Market by Country
7.2.1.2 Europe Open Spine Surgery Market by Country
7.2.2 Europe Spinal Fusion Devices Market by Type
7.2.2.1 Europe Thoracolumbar Devices Market by Country
7.2.2.2 Europe Cervical Fixation Devices Market by Country
7.2.2.3 Europe Interbody Fusion Devices Market by Country
7.2.3 Europe Spinal Fusion Devices Market by End User
7.2.3.1 Europe Hospitals Market by Country
7.2.3.2 Europe Specialty Clinics Market by Country
7.2.3.3 Europe Others Market by Country
7.2.4 Europe Spinal Fusion Devices Market by Country
7.2.4.1 Germany Spinal Fusion Devices Market
7.2.4.1.1 Germany Spinal Fusion Devices Market by Surgery
7.2.4.1.2 Germany Spinal Fusion Devices Market by Type
7.2.4.1.3 Germany Spinal Fusion Devices Market by End User
7.2.4.2 UK Spinal Fusion Devices Market
7.2.4.2.1 UK Spinal Fusion Devices Market by Surgery
7.2.4.2.2 UK Spinal Fusion Devices Market by Type
7.2.4.2.3 UK Spinal Fusion Devices Market by End User
7.2.4.3 France Spinal Fusion Devices Market
7.2.4.3.1 France Spinal Fusion Devices Market by Surgery
7.2.4.3.2 France Spinal Fusion Devices Market by Type
7.2.4.3.3 France Spinal Fusion Devices Market by End User
7.2.4.4 Russia Spinal Fusion Devices Market
7.2.4.4.1 Russia Spinal Fusion Devices Market by Surgery
7.2.4.4.2 Russia Spinal Fusion Devices Market by Type
7.2.4.4.3 Russia Spinal Fusion Devices Market by End User
7.2.4.5 Spain Spinal Fusion Devices Market
7.2.4.5.1 Spain Spinal Fusion Devices Market by Surgery
7.2.4.5.2 Spain Spinal Fusion Devices Market by Type
7.2.4.5.3 Spain Spinal Fusion Devices Market by End User
7.2.4.6 Italy Spinal Fusion Devices Market
7.2.4.6.1 Italy Spinal Fusion Devices Market by Surgery
7.2.4.6.2 Italy Spinal Fusion Devices Market by Type
7.2.4.6.3 Italy Spinal Fusion Devices Market by End User
7.2.4.7 Rest of Europe Spinal Fusion Devices Market
7.2.4.7.1 Rest of Europe Spinal Fusion Devices Market by Surgery
7.2.4.7.2 Rest of Europe Spinal Fusion Devices Market by Type
7.2.4.7.3 Rest of Europe Spinal Fusion Devices Market by End User
7.3 Asia Pacific Spinal Fusion Devices Market
7.3.1 Asia Pacific Spinal Fusion Devices Market by Surgery
7.3.1.1 Asia Pacific Minimally Invasive Spine Surgery Market by Country
7.3.1.2 Asia Pacific Open Spine Surgery Market by Country
7.3.2 Asia Pacific Spinal Fusion Devices Market by Type
7.3.2.1 Asia Pacific Thoracolumbar Devices Market by Country
7.3.2.2 Asia Pacific Cervical Fixation Devices Market by Country
7.3.2.3 Asia Pacific Interbody Fusion Devices Market by Country
7.3.3 Asia Pacific Spinal Fusion Devices Market by End User
7.3.3.1 Asia Pacific Hospitals Market by Country
7.3.3.2 Asia Pacific Specialty Clinics Market by Country
7.3.3.3 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Spinal Fusion Devices Market by Country
7.3.4.1 China Spinal Fusion Devices Market
7.3.4.1.1 China Spinal Fusion Devices Market by Surgery
7.3.4.1.2 China Spinal Fusion Devices Market by Type
7.3.4.1.3 China Spinal Fusion Devices Market by End User
7.3.4.2 Japan Spinal Fusion Devices Market
7.3.4.2.1 Japan Spinal Fusion Devices Market by Surgery
7.3.4.2.2 Japan Spinal Fusion Devices Market by Type
7.3.4.2.3 Japan Spinal Fusion Devices Market by End User
7.3.4.3 India Spinal Fusion Devices Market
7.3.4.3.1 India Spinal Fusion Devices Market by Surgery
7.3.4.3.2 India Spinal Fusion Devices Market by Type
7.3.4.3.3 India Spinal Fusion Devices Market by End User
7.3.4.4 South Korea Spinal Fusion Devices Market
7.3.4.4.1 South Korea Spinal Fusion Devices Market by Surgery
7.3.4.4.2 South Korea Spinal Fusion Devices Market by Type
7.3.4.4.3 South Korea Spinal Fusion Devices Market by End User
7.3.4.5 Singapore Spinal Fusion Devices Market
7.3.4.5.1 Singapore Spinal Fusion Devices Market by Surgery
7.3.4.5.2 Singapore Spinal Fusion Devices Market by Type
7.3.4.5.3 Singapore Spinal Fusion Devices Market by End User
7.3.4.6 Malaysia Spinal Fusion Devices Market
7.3.4.6.1 Malaysia Spinal Fusion Devices Market by Surgery
7.3.4.6.2 Malaysia Spinal Fusion Devices Market by Type
7.3.4.6.3 Malaysia Spinal Fusion Devices Market by End User
7.3.4.7 Rest of Asia Pacific Spinal Fusion Devices Market
7.3.4.7.1 Rest of Asia Pacific Spinal Fusion Devices Market by Surgery
7.3.4.7.2 Rest of Asia Pacific Spinal Fusion Devices Market by Type
7.3.4.7.3 Rest of Asia Pacific Spinal Fusion Devices Market by End User
7.4 LAMEA Spinal Fusion Devices Market
7.4.1 LAMEA Spinal Fusion Devices Market by Surgery
7.4.1.1 LAMEA Minimally Invasive Spine Surgery Market by Country
7.4.1.2 LAMEA Open Spine Surgery Market by Country
7.4.2 LAMEA Spinal Fusion Devices Market by Type
7.4.2.1 LAMEA Thoracolumbar Devices Market by Country
7.4.2.2 LAMEA Cervical Fixation Devices Market by Country
7.4.2.3 LAMEA Interbody Fusion Devices Market by Country
7.4.3 LAMEA Spinal Fusion Devices Market by End User
7.4.3.1 LAMEA Hospitals Market by Country
7.4.3.2 LAMEA Specialty Clinics Market by Country
7.4.3.3 LAMEA Others Market by Country
7.4.4 LAMEA Spinal Fusion Devices Market by Country
7.4.4.1 Brazil Spinal Fusion Devices Market
7.4.4.1.1 Brazil Spinal Fusion Devices Market by Surgery
7.4.4.1.2 Brazil Spinal Fusion Devices Market by Type
7.4.4.1.3 Brazil Spinal Fusion Devices Market by End User
7.4.4.2 Argentina Spinal Fusion Devices Market
7.4.4.2.1 Argentina Spinal Fusion Devices Market by Surgery
7.4.4.2.2 Argentina Spinal Fusion Devices Market by Type
7.4.4.2.3 Argentina Spinal Fusion Devices Market by End User
7.4.4.3 UAE Spinal Fusion Devices Market
7.4.4.3.1 UAE Spinal Fusion Devices Market by Surgery
7.4.4.3.2 UAE Spinal Fusion Devices Market by Type
7.4.4.3.3 UAE Spinal Fusion Devices Market by End User
7.4.4.4 Saudi Arabia Spinal Fusion Devices Market
7.4.4.4.1 Saudi Arabia Spinal Fusion Devices Market by Surgery
7.4.4.4.2 Saudi Arabia Spinal Fusion Devices Market by Type
7.4.4.4.3 Saudi Arabia Spinal Fusion Devices Market by End User
7.4.4.5 South Africa Spinal Fusion Devices Market
7.4.4.5.1 South Africa Spinal Fusion Devices Market by Surgery
7.4.4.5.2 South Africa Spinal Fusion Devices Market by Type
7.4.4.5.3 South Africa Spinal Fusion Devices Market by End User
7.4.4.6 Nigeria Spinal Fusion Devices Market
7.4.4.6.1 Nigeria Spinal Fusion Devices Market by Surgery
7.4.4.6.2 Nigeria Spinal Fusion Devices Market by Type
7.4.4.6.3 Nigeria Spinal Fusion Devices Market by End User
7.4.4.7 Rest of LAMEA Spinal Fusion Devices Market
7.4.4.7.1 Rest of LAMEA Spinal Fusion Devices Market by Surgery
7.4.4.7.2 Rest of LAMEA Spinal Fusion Devices Market by Type
7.4.4.7.3 Rest of LAMEA Spinal Fusion Devices Market by End User
Chapter 8. Company Profiles
8.1 Zimmer Biomet Holdings, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental & Regional Analysis
8.1.4 Research & Development Expense
8.2 Johnson & Johnson
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.3 Stryker Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 B. Braun Melsungen AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 Medtronic PLC
8.5.1 Company overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Acquisition and Mergers:
8.6 Alphatec Holdings Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.7 Globus Medical, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.8 NuVasive, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Product Launches and Product Expansions:
8.9 Orthofix Medical, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Product Launches and Product Expansions:
8.10. Exactech, Inc.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:

Companies Mentioned

  • Zimmer Biomet Holdings, Inc.
  • Johnson & Johnson
  • Stryker Corporation
  • B. Braun Melsungen AG
  • Medtronic PLC
  • Alphatec Holdings Inc.
  • Globus Medical, Inc.
  • NuVasive, Inc.
  • Orthofix Medical, Inc.
  • Exactech, Inc.

Methodology

Loading
LOADING...